BMJ Open:医院质量管理和患者因素之间关系的研究(DUQuA)

2015-12-29 phylis 译 MedSci原创

背景:尽管在医疗保健治疗和安全的研究不断增加,但很少有证据表明医院管理方式和患者因素的关系,限制了对大规模变化的了解。“加深对澳大利亚质量的了解“()研究旨在评估1组织和部门质量管理系统(QMS),临床医生的领导力和文化;2澳大利亚医院中临床治疗过程,临床预后和患者对护理评价部分。方法与分析:DUQuA是一项全国性,多层次,横断面的研究,在医院,科室,专业和患者水平收集数据。样本量至少43个医院才

背景:尽管关于医疗保健治疗和安全的研究不断增加,但很少有证据表明医院管理方式和患者因素的关系,这限制了对大规模变化的了解。“加深对澳大利亚质量的了解“(DUQuA)研究旨在评估:1.组织和部门质量管理系统(QMS),临床医生的领导力和文化;2.澳大利亚医院中临床治疗过程,临床预后和患者对护理评价部分。

方法与分析:DUQuA是一项全国性,多层次,横断面的研究,在医院、科室、专业和患者水平收集数据。样本量至少43个医院才能满足研究的效度。澳大利亚管辖区共有70家医院满足纳入标准,邀请其作为受试者。受试者将包括医院质量管理专业人员、临床医生、卒中患者、急性心肌梗死患者和髋部骨折患者。应用循证或管理工具评估组织和管理部门的QMS、临床领导力和文化、患者对安全性的看法、临床治疗过程和患者预后。数据分析包括简单相关,线性和logistic回归和多变量建模。多变量建模方法可确定多变量预后对医院和科室水平的影响,及变量的影响因素。

伦理与传播:已获得伦理学认可。研究结果将传送至由数据驱动推荐的国家和国际基准报告的个别医院。这项开创性的国家研究将影响澳大利亚和国际医院对医院质量和安全系统及临床处理过程的决策。

原文出处:

Taylor N, Clay-Williams R, et al. Deepening our Understanding of Quality in Australia (DUQuA): a study protocol for a nationwide, multilevel analysis of relationships between hospital quality management systems and patient factors. BMJ Open. 2015 Dec 7.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1950664, encodeId=ccae1950664b5, content=<a href='/topic/show?id=e5bf9241085' target=_blank style='color:#2F92EE;'>#质量管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92410, encryptionId=e5bf9241085, topicName=质量管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Mon May 09 00:37:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725979, encodeId=e5f01e2597971, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Apr 22 17:37:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847822, encodeId=03f4184e822e6, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Jun 15 13:37:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51829, encodeId=e7bc51829a0, content=没弄明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Mon Jan 04 18:30:00 CST 2016, time=2016-01-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1950664, encodeId=ccae1950664b5, content=<a href='/topic/show?id=e5bf9241085' target=_blank style='color:#2F92EE;'>#质量管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92410, encryptionId=e5bf9241085, topicName=质量管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Mon May 09 00:37:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725979, encodeId=e5f01e2597971, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Apr 22 17:37:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847822, encodeId=03f4184e822e6, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Jun 15 13:37:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51829, encodeId=e7bc51829a0, content=没弄明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Mon Jan 04 18:30:00 CST 2016, time=2016-01-04, status=1, ipAttribution=)]
    2016-04-22 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=1950664, encodeId=ccae1950664b5, content=<a href='/topic/show?id=e5bf9241085' target=_blank style='color:#2F92EE;'>#质量管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92410, encryptionId=e5bf9241085, topicName=质量管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Mon May 09 00:37:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725979, encodeId=e5f01e2597971, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Apr 22 17:37:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847822, encodeId=03f4184e822e6, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Jun 15 13:37:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51829, encodeId=e7bc51829a0, content=没弄明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Mon Jan 04 18:30:00 CST 2016, time=2016-01-04, status=1, ipAttribution=)]
    2016-06-15 gaoxiaoe
  4. [GetPortalCommentsPageByObjectIdResponse(id=1950664, encodeId=ccae1950664b5, content=<a href='/topic/show?id=e5bf9241085' target=_blank style='color:#2F92EE;'>#质量管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92410, encryptionId=e5bf9241085, topicName=质量管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Mon May 09 00:37:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725979, encodeId=e5f01e2597971, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Apr 22 17:37:00 CST 2016, time=2016-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847822, encodeId=03f4184e822e6, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Jun 15 13:37:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51829, encodeId=e7bc51829a0, content=没弄明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Mon Jan 04 18:30:00 CST 2016, time=2016-01-04, status=1, ipAttribution=)]
    2016-01-04 lyh994

    没弄明白

    0